Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapy

Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapy

US Patent 11396647 · Granted Jul 26, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Engineered primate cystine/cysteine degrading enzymes for therapeutic uses2024
Human Kynureninase enzymes and uses thereof2024
Human-enzyme mediated depletion of homocysteine for treating patients with hyper2024
Human kynureninase enzymes and uses thereof2023
Nicotine degrading enzyme variants2023
Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapy2023
Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological prepa2023
Human kynureninase enzyme variants having improved pharmacological properties2023
Nucleic acids encoding kynurenine depleting enzymes2022
Engineered primate cystine/cysteine degrading enzymes as antineogenic agents2022
Administration of kynurenine depleting enzymes for tumor therapy2021
Enzyme-mediated depletion of adenosine and/or methylthioadenosine2021